This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
L02BA
1 out of 7 registries used, show all original rules.
5513
Check minimum number of events
Min. number of events
3
5513
Include endpoints None
5513
Remove individuals based on genotype QC
5324
RX_L02BA
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF3
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
L02BA Anti-estrogens
based on the number of shared cases.
Broader endpoints:
- Medicines for HER+ breast cancer
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5324 | 5226 | 98 |
| Unadjusted prevalence (%) | 1.29 | 2.27 | 0.05 |
| Mean age at first event (years) | 56.68 | 56.61 | 60.49 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: RX_L02BA – L02BA Anti-estrogens
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after L02BA Anti-estrogens
↥Endpoint not on priority list, no data to show.